Literature DB >> 26695146

Adding Mendelian randomization to a meta-analysis-a burgeoning opportunity.

Wenquan Niu1, Mingliang Gu2.   

Abstract

Current literature is teeming with tens of thousands of meta-analyses, but only a small fraction made seminal contributions to enriching our understanding of the mechanisms of carcinogenesis, possibly due to chance, bias, confounding, or reverse causality. The incorporation of Mendelian randomization (MR) with a meta-analysis has revolutionized traditional practice and is emerging as a viable technique to strengthen causal unconfounded inferences from observational data. We therefore highlight the importance of integrated MR meta-analysis in cancer epidemiology and provide an overview of three existing instrumental selection strategies in medical literature.

Entities:  

Keywords:  Causality; Mendelian randomization; Meta-analysis

Mesh:

Year:  2015        PMID: 26695146     DOI: 10.1007/s13277-015-4680-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

1.  Complement factor H polymorphism in age-related macular degeneration.

Authors:  Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

2.  Mendelian randomization suggests no causal association between C-reactive protein and carotid intima-media thickness in the young Finns study.

Authors:  Mika Kivimäki; Debbie A Lawlor; Carita Eklund; George Davey Smith; Mikko Hurme; Terho Lehtimäki; Jorma S A Viikari; Olli T Raitakari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-04       Impact factor: 8.311

Review 3.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges.

Authors:  Mark I McCarthy; Gonçalo R Abecasis; Lon R Cardon; David B Goldstein; Julian Little; John P A Ioannidis; Joel N Hirschhorn
Journal:  Nat Rev Genet       Date:  2008-05       Impact factor: 53.242

Review 4.  Mendelian Randomization for Strengthening Causal Inference in Observational Studies: Application to Gene × Environment Interactions.

Authors:  George Davey Smith
Journal:  Perspect Psychol Sci       Date:  2010-10-11

5.  Apolipoprotein E isoforms, serum cholesterol, and cancer.

Authors:  M B Katan
Journal:  Lancet       Date:  1986-03-01       Impact factor: 79.321

Review 6.  The evolving discipline of molecular epidemiology of cancer.

Authors:  Margaret R Spitz; Melissa L Bondy
Journal:  Carcinogenesis       Date:  2009-12-18       Impact factor: 4.944

7.  Causal relevance of circulating adiponectin with cancer: a meta-analysis implementing Mendelian randomization.

Authors:  Yuan Pei; Yue Xu; Wenquan Niu
Journal:  Tumour Biol       Date:  2014-10-02

8.  An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization.

Authors:  Cosetta Minelli; John R Thompson; Martin D Tobin; Keith R Abrams
Journal:  Am J Epidemiol       Date:  2004-09-01       Impact factor: 4.897

9.  Aldehyde dehydrogenase 2 and head and neck cancer: a meta-analysis implementing a Mendelian randomization approach.

Authors:  Stefania Boccia; Mia Hashibe; Paola Gallì; Emma De Feo; Takahiro Asakage; Tomoko Hashimoto; Akio Hiraki; Takahiko Katoh; Takeshi Nomura; Akira Yokoyama; Cornelia M van Duijn; Gualtiero Ricciardi; Paolo Boffetta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

10.  Mendelian randomization of blood lipids for coronary heart disease.

Authors:  Michael V Holmes; Folkert W Asselbergs; Tom M Palmer; Fotios Drenos; Matthew B Lanktree; Christopher P Nelson; Caroline E Dale; Sandosh Padmanabhan; Chris Finan; Daniel I Swerdlow; Vinicius Tragante; Erik P A van Iperen; Suthesh Sivapalaratnam; Sonia Shah; Clara C Elbers; Tina Shah; Jorgen Engmann; Claudia Giambartolomei; Jon White; Delilah Zabaneh; Reecha Sofat; Stela McLachlan; Pieter A Doevendans; Anthony J Balmforth; Alistair S Hall; Kari E North; Berta Almoguera; Ron C Hoogeveen; Mary Cushman; Myriam Fornage; Sanjay R Patel; Susan Redline; David S Siscovick; Michael Y Tsai; Konrad J Karczewski; Marten H Hofker; W Monique Verschuren; Michiel L Bots; Yvonne T van der Schouw; Olle Melander; Anna F Dominiczak; Richard Morris; Yoav Ben-Shlomo; Jackie Price; Meena Kumari; Jens Baumert; Annette Peters; Barbara Thorand; Wolfgang Koenig; Tom R Gaunt; Steve E Humphries; Robert Clarke; Hugh Watkins; Martin Farrall; James G Wilson; Stephen S Rich; Paul I W de Bakker; Leslie A Lange; George Davey Smith; Alex P Reiner; Philippa J Talmud; Mika Kivimäki; Debbie A Lawlor; Frank Dudbridge; Nilesh J Samani; Brendan J Keating; Aroon D Hingorani; Juan P Casas
Journal:  Eur Heart J       Date:  2014-01-27       Impact factor: 29.983

View more
  2 in total

1.  Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique.

Authors:  Fernando Pires Hartwig; Neil Martin Davies; Gibran Hemani; George Davey Smith
Journal:  Int J Epidemiol       Date:  2016-12-01       Impact factor: 7.196

2.  Enhanced circulating transforming growth factor beta 1 is causally associated with an increased risk of hepatocellular carcinoma: a mendelian randomization meta-analysis.

Authors:  Wei-Qun Lu; Ji-Liang Qiu; Zhi-Liang Huang; Hai-Ying Liu
Journal:  Oncotarget       Date:  2016-12-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.